Epcoritamab in relapsed/refractory large B-cell lymphoma: 2-year follow-up from the pivotal EPCORE NHL-1 trial
复发/难治性大B细胞淋巴瘤患者接受Epcoritab治疗:关键性EPCORE NHL-1试验的2年随访结果
期刊:Leukemia
影响因子:13.4
doi:10.1038/s41375-024-02410-8
Thieblemont, Catherine; Karimi, Yasmin H; Ghesquieres, Herve; Cheah, Chan Y; Clausen, Michael Roost; Cunningham, David; Jurczak, Wojciech; Do, Young Rok; Gasiorowski, Robin; Lewis, David John; Kim, Tae Min; van der Poel, Marjolein; Poon, Michelle Limei; Feldman, Tatyana; Linton, Kim M; Sureda, Anna; Hutchings, Martin; Dinh, Minh H; Kilavuz, Nurgul; Soong, David; Mark, Thomas; Sacchi, Mariana; Phillips, Tycel; Lugtenburg, Pieternella J